2025 fourth_quarter Filing

Income

$20K

Filed

February 3, 2026

Lobbying Activities

Health IssuesView all

Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Budget/AppropriationsView all

Increased funding for longevity research at the National Institutes of Health

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Lobbyists (1)

JOHN GUY